Ganetespib NSCLC
Laufzeit: 01.01.2011 - 31.12.2012
imported
Kurzfassung
A randomized phase Phase IIB/III study of Ganetespib (STA-9090) in combination with Docetaxel versus Docetaxel alone in subjects with stage IIIB or IV non-small-cell lung cancer
